Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
EXCH
HLB innoVation
★

NDR for Institutional Investors (Introducing Subsidiary Verismo Therapeutics)

  05/03/2026, 07:00 AM
EXCH
HLB innoVation
★

Conversion Price Adjustment Due to Stock Merger (5:1) (3rd CB)

  05/02/2026, 09:27 PM
  • «
  • 1
  • 2
  • »
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.